Heartland Bank & Trust Co Cuts Stock Holdings in Danaher Co. (NYSE:DHR)

Heartland Bank & Trust Co reduced its stake in Danaher Co. (NYSE:DHR) by 5.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,077 shares of the conglomerate’s stock after selling 162 shares during the quarter. Heartland Bank & Trust Co’s holdings in Danaher were worth $706,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher during the 4th quarter valued at $31,000. Teachers Insurance & Annuity Association of America purchased a new stake in Danaher during the third quarter valued at about $39,000. MidAtlantic Capital Management Inc. bought a new stake in Danaher during the third quarter worth about $40,000. FSA Wealth Management LLC purchased a new position in shares of Danaher in the 3rd quarter worth about $50,000. Finally, Darwin Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at about $55,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DHR has been the subject of several research reports. KeyCorp upped their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Evercore ISI boosted their price target on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective on the stock in a research note on Thursday, October 31st. Finally, Citigroup lowered their target price on Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $285.55.

Danaher Trading Up 0.1 %

NYSE:DHR opened at $245.95 on Monday. Danaher Co. has a 12 month low of $225.42 and a 12 month high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $235.33 and a 200-day moving average price of $253.62. The stock has a market cap of $177.65 billion, a price-to-earnings ratio of 46.94, a P/E/G ratio of 4.43 and a beta of 0.83.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s payout ratio is 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.